geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 46063

Chapter 46063 provides bibliographic information on scholary research in geography and in the life sciences.



FAB-MS characterization of sialyl Lewis x determinants on polylactosamine chains of human airway mucins secreted by patients suffering from cystic fibrosis or chronic bronchitis. Glycoconjugate Journal 18(9): 699-708

FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy. Annals of Oncology 5(1): 95-97

FACC gene mutations and early prenatal diagnosis of Fanconi's anaemia. Lancet 342(8872): 686-686

FACCT (Foundation for Accountability): a large measure of quality. Journal of Ahima 68(6): 41-46

FACE: fear of loss of face and the five hazardous attitudes concept. International Journal of Aviation Psychology 9(4): 403-411

FACES III and the Kvebaek Family Sculpture Technique as measures of cohesion and closeness. Family Process 32(2): 221-233

FACS analysis-a new and accurate tool in the diagnosis of lymphoma in the cerebrospinal fluid. Clinica Chimica Acta; International Journal of Clinical Chemistry 317(1-2): 101-107

FACS-sorted spleen and Peyer's patch dendritic cells induce different responses in Th0 clones. Advances in Experimental Medicine and Biology 417: 357-362

FAD and substrate analogs as probes for lysine N6-hydroxylase from Escherichia coli EN 222. European Journal of Biochemistry 213(3): 995-1002

FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction. Neurobiology of Aging 23(3): 335-348

FAD-mediated enzymatic conversion of NAD+ to NADH: application to chiral synthesis of L-lactate. Bioorganic & Medicinal Chemistry Letters 8(20): 2819-2824

FADD and TRADD expression and apoptosis in primary hepatocellular carcinoma. World Journal of Gastroenterology 6(2): 223-227

FADD is required for multiple signaling events downstream of the receptor Fas. Cell Growth & Differentiation 10(12): 797-804

FADE: a strategy for action in the mild stage of dementia. British Journal of Nursing 4(22): 1335-1339

FAEE injury in rats: relevant to alcoholic pancreatitis?. Gastroenterology 114(1): 229-230

FAH Foundation formed; scholarship awards will be major project. Review - Federation of American Hospitals 12(4): 49-49

FAH establishes nursing panel, asks changes in Planning, HMO Acts. Review - Federation of American Hospitals 14(1): 10-10

FAH hits insurers' ads citing cost shift. American Medical News 26(16): 3, 11-3, 11

FAH manual outlines control programs on risk management for hospital use. Review - Federation of American Hospitals 10(1): 13-4, 16-8

FAH names Walker director of administrative services. Review - Federation of American Hospitals 12(1): 20-20

FAH president favors a cost-sharing incentive health plan. Review - Federation of American Hospitals 12(5): 34-34

FAH president says N.D. victory emphasizes feeling on curbs. Review - Federation of American Hospitals 11(7): 18-18

FAH scholarship total rises to 57 with 14 new winners in '84. Review - Federation of American Hospitals 18(1): 114-116

FAH voices viewpoints on competitive approach to health care delivery. Review - Federation of American Hospitals 13(2): 48-49

FAH wins decision on stock maintenance cost. Review - Federation of American Hospitals 11(4): 8-8

FAHCT accreditation: common deficiencies during on-site inspections. CytoTherapy 2(3): 213-220

FAHS (Federation of American Health Systems) 1991 conference and business exposition. Review 23(6): 10-1, 43

FAHS leads way for industry-wide electronic data interchange system. Review 21(3): 56-58

FAHS refers Stark II reactions to HCFA. Hospital Outlook 1(5): 4-4

FAHS study finds nearly one third of vendors dropped their group contracts during 1987. Health Industry Today 51(6): 14-5, 74

FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients. Journal of Magnetic Resonance Imaging 16(2): 137-146

FAIR exempting separate T (1) measurement (FAIREST): a novel technique for online quantitative perfusion imaging and multi-contrast fMRI. Nmr in Biomedicine 14(7-8): 507-516

FAK regulates tyrosine phosphorylation of CAS, paxillin, and PYK2 in cells expressing v-Src, but is not a critical determinant of v-Src transformation. Journal of Cellular Biochemistry 84(2): 377-388

FAK-independent regulation of prolidase activity and collagen biosynthesis in MCF-7 cells. Folia Histochemica et Cytobiologica 39 Suppl 2: 212-213

FALSIFLORA, the tomato orthologue of FLORICAULA and LEAFY, controls flowering time and floral meristem identity. Plant Journal 20(6): 685-693

FAM as a palliative chemotherapy for gastric cancer with bone metastasis. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 23(1): 107-110

FAMSAN places client needs first. Case scenarios for training and group discussion. Family Planning Manager 5(1 Suppl): 1-4

FANCA protein binds FANCG proteins in an intracellular complex. Blood 95(2): 725-726

FANS: what should the patient know?. Rivista Dell'infermiere 15(4): 196-199

FANTOM DB: database of Functional Annotation of RIKEN Mouse cDNA Clones. Nucleic Acids Research 30(1): 116-118

FAO aims for audience of two billion. Psd Communication Newsletter 2(1): 1-1

FAP-1: a protein tyrosine phosphatase that is involved in Fas-mediated apoptosis. Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme 43(8 Suppl): 1193-1199

FAP52 - a new partner for filamin in actin cytoskeleton organization. Trends in Cell Biology 12(5): 213-213

FAQ re abbreviations. Frequently asked question. British Dental Journal 188(3): 119-119

FAQs & fables about protective clothing. Occupational Health & Safety 69(7): 42-4, 46, 53-4

FAQs about nurse practitioners. Michigan Nurse 74(9): 8-9

FAQs about the West Nile virus. Survival News: 15-16

FAQs on ASPs. What application service providers can do for you. Materials Management in Health Care 10(1): 24-24

FAQs on NP certification. Advance for Nurse Practitioners 9(4): 27-27

FARMAC: a program designed for monitoring the prescription of antimicrobials in hospitals. Gaceta Medica de Mexico 136(2): 107-111

FARMACIN: a pharmacology database. Medinfo. Medinfo 8 Pt 2: 1121-1122

FAS 116 and 117: the implementation process. Healthcare Financial Management 47(10): 68-69

FAS 33: accurately recording effects of changing prices. Healthcare Financial Management 41(2): 56-64

FAS subscribers surveyed: hospitals increase use of capital budgeting process. Healthcare Financial Management 36(6): 70, 73-4, 76 Passim

FAS/FAE: impact on children. Journal of Child Health Care 3(3): 31-34

FASA (Federal Acquisition Streamlining Act of 1994) impact still debated as price list stays on hold. Hospital Material Dollar Sign Management 22(9): 1, 12-3

FASA statistics reveal 1981 top 10 procedures. Same-Day Surgery 6(5): 58-59

FASA statistics reveal top 10 procedures. Same-Day Surgery 5(4): 47-49

FASB #95: what is it?. Healthcare Bottom Line 6(2): 1-3

FASB (Financial Accounting Standards Board) issues new accounting rules for debt and equity securities. Healthcare Financial Management 48(10): 34-41

FASB (Financial Accounting Standards Board) proposal changes retiree healthcare benefit accounting. Healthcare Financial Management 43(7): 48-9, 52-4, 56-7

FASB (Financial Accounting Standards Board) proposes changes in not-for-profit reporting. Healthcare Financial Management 47(4): 39-42, 44-6, 48-9

FASB 95--a tool for identifying cash flow problems. Healthcare Financial Management 43(6): 72, 74, 76-7

FASB Statement No. 132 simplifies benefits disclosures. Healthcare Financial Management 53(6): 68-72, 74, 76

FASB Statement No. 136 clarifies transfers of assets. Healthcare Financial Management 54(3): 58-61

FASB considers consolidation rules change. Healthcare Financial Management 49(9): 84-85

FASB may alter financial rules. Modern Healthcare 24(48): 28-28

FASB proposal targets retiree health benefits. Risk Management 37(12): 47-49

FASB proposes consistent treatment for contributions. Healthcare Financial Management 45(5): 128-129

FASCIATA genes for chromatin assembly factor-1 in arabidopsis maintain the cellular organization of apical meristems. Cell 104(1): 131-142

FASCs now growing slowly; surgical centers the prototype. Employee Benefit Plan Review 31(9): 34-34

FASE (fast advanced spin echo). Nihon Rinsho. Japanese Journal of Clinical Medicine 56(11): 2783-2791

FASEB Federal Funding Consensus Conference FY 2000. Executive summary. Physiologist 42(1): 1, 3-1, 3

FASSST: a new gas-phase analytical tool. Analytical Chemistry 70(21): 719a-727a

FAST sequences optimization for contrast media pharmacokinetic quantification in tissue. Journal of Magnetic Resonance Imaging 14(6): 771-778

FAST-2 is a mammalian winged-helix protein which mediates transforming growth factor beta signals. Molecular and Cellular Biology 19(1): 424-430

FAUSTLOS--a curriculum for promoting social competence and preventing aggressive and violent behavior in children. Praxis der Kinderpsychologie und Kinderpsychiatrie 46(3): 236-247

FAWC calls for rigorous enforcement of welfare legislation. Farm Animal Welfare Council. Veterinary Record 145(7): 178-178

FAWC's 'five freedoms'. Veterinary Record 138(26): 651-651

FAWC's concerns about leg problems in broilers. Farm Animal Welfare Council. Veterinary Record 148(1): 3-4

FAWSETS: flow-driven arterial water stimulation with elimination of tissue signal. Journal of Magnetic Resonance 124(1): 240-244

FAmily planning in Taiwan. British Journal of Family Planning 24(2): 78-80

FBG and TC/HDL ratios in type 2 diabetes mellitus. Journal of Ayub Medical College, Abbottabad 13(2): 42-44

FBI agent: hospitals should seek training in proper infant footprinting. Hospital Security and Safety Management 16(1): 3-4

FBI investigates cardiac surgeries. Bmj 325(7373): 1130-1130

FBI probes turnpike pact awarded to Ohio Blues. Modern Healthcare 23(35): 27-27

FBI reports to Congress: widespread Medicare corruption found. American Medical News 23(24): 10-10

FBI says Medi-fraud attracts even the mob. Medical World News 21(18): 22-22

FBI seeks power to make health fraud more costly. Modern Healthcare 25(13): 4-4

FBI targeting healthcare. Modern Healthcare 22(6): 22-22

FBI widens Chicago hospital probe. Modern Healthcare 26(16): 32-33

FBI's Employee Assistance Program: an advanced law enforcement model. International Journal of Emergency Mental Health 1(2): 109-114

FBeNg(+) (Ng=He, Ne, Ar): Suitable Cations for Salts of the Lightest Noble Gases? This work was supported by the Italian Ministero dell' Università e della Ricerca Scientifica e Tecnologica (MURST) and the Consiglio Nazionale delle Ricerche (CNR). Angewandte Chemie 39(9): 1690-1692

FC gamma RIIa polymorphism in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 20(6): 841-844

FC gamma receptor mediated phagocytosis by human neutrophil cytoplasts. Inflammation 23(3): 253-262

FCC regulation of EMS telecommunications. Emergency Medical Services 13(4): 22, 24-22, 24

FCC rejects DOT petition; cites AHA comments. Health Law Vigil 3(22): 5-6

FCC ruling in Centrex-CO access charge case. Health Law Vigil 7(18): 2-3

FCC urges companies to standardize telemedicine equipment. Telemedicine and Virtual Reality 2(9): 99-99

FCC warns hospitals of possible beeper tune-out. Health Care Week 2(25): 2-2

FCC's approval of the resale and sharing of WATS could afford hospitals an opportunity to offset communications expenditures. Health Law Vigil 5(5): 9-10

FCC's deregulation of telecommunication systems could affect 75% of all hospitals. Health Law Vigil 4(4): 3-5

FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis. Invasion & Metastasis 15(5-6): 222-231

FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects. Journal of Steroid Biochemistry and Molecular Biology 58(3): 299-305

FCIM defines the internist. Internist 21(9): 19-21

FCP 3P1. CardioRex. Drugs in R&d 1(6): 481-482

FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. European Journal of Immunology 32(1): 87-96

FDA & Y2K. Preparing for the new millennium. Fda Consumer 33(6): 6-11

FDA & clinical software vendors: a line in the sand?. Healthcare Informatics 13(6): 100-2, 104, 106

FDA 'not backing away' from universal leukoreduction. Cap Today 14(8): 5-6

FDA 1974: scrutiny from without and within. Fda Consumer 9(3): 4-15

FDA Advisory Committee stalemates on delavirdine. Aids Patient Care and Stds 11(2): 96-97

FDA Arthritis Advisory Committee Meeting: juvenile rheumatoid arthritis drug evaluation guidelines; over-the-counter naproxen?. Arthritis and Rheumatism 37(1): 137-138

FDA Blood Products Advisory Committee evaluates glove use in blood donation centers. Aids Patient Care 9(1): 43-43

FDA Clinical Chemistry and Clinical Toxicology Devices Panel. Diabetes Technology & Therapeutics 1(2): 201-202

FDA Committee recommends clearance for HIVID combination therapy. Aids Patient Care and Stds 10(3): 186-186

FDA Internet regulation? Public comment accepted until December 16. Food and Drug Administration. Aids Treatment News: 7-8

FDA Modernization Act of 1997: modifications to the list of recognized standards; availability; withdrawal of draft guidance "Use of IEC 60601 standards; medical electrical equipment"--FDA. Notice. Federal Register 63(200): 55617-55630

FDA Modernization Act: implications for oncology. Oncology 12(11a): 139-141

FDA NPRM would standardize blood labeling to permit inventory automation. Health Law Vigil 3(24): 6-7

FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky. Health News 8(10): 1-2

FDA OTC advisory group needs practitioners. American Pharmacy Ns33(4): 4, 90-4, 90

FDA Panel report: January 1998. Circulation 97(23): 2295-2296

FDA Policy Statement: medical computer products. Computers in Healthcare 8(13): 11-12

FDA Proposal for Classification of "Analyte-specific Reagents". Molecular Diagnosis 1(2): 153-154

FDA a main culprit in delayed access to technology. Mlo: Medical Laboratory Observer 27(8): 23-24

FDA accuses Red Cross of unsafe practices. Inspections at embattled blood bank turn up 'serious' violations. Modern Healthcare 31(51): 10-10

FDA action spurs change in groups' drug programs. Hospital Material Dollar Sign Management 14(11): 1, 13-4

FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation. Value in Health 5(5): 390-397

FDA acts on estrogen, progestin labeling. Fda Consumer 11(9): 3-3

FDA addresses childhood iron poisoning. American Pharmacy Ns35(1): 10-10

FDA admits to lacking control over counterfeit drug imports. American Journal of Health-System Pharmacy 57(14): 1296-1297

FDA advisers vote against OTC Pravachol. Diabetes Technology & Therapeutics 2(3): 483-484

FDA advisers warn of more deaths if drug is relaunched. Bmj 325(7364): 561-561

FDA advises blood centers on phase-in of AIDS test. Mlo: Medical Laboratory Observer 17(4): 21-23

FDA advisors recommend approval of taxol for node-positive breast cancer. Oncologist 4(5): 430-431

FDA advisory committee deadlocks on delavirdine. Food and Drug Administration. Aids Treatment News: 3-5

FDA advisory committees meet January 26 on Salk HIV-1 immunogen. Aids Treatment News: 1-2

FDA advisory panel okays HIV vaccine. Bio/Technology 13(3): 205-206

FDA advisory panel recommends approval for Depo-Provera. Contraceptive Technology Update 13(10): 159-160

FDA advisory panels recommend Lotronex be put back on market. Bmj 324(7345): 1053-1053

FDA alert: protease inhibitors reportedly cause bleeding. Aids Patient Care and Stds 10(6): 378-378

FDA allows controversial bowel drug back on to market. Lancet 359(9323): 2095-2095

FDA allows ionizing radiation in shell eggs. Journal of the American Veterinary Medical Association 217(6): 810-810

FDA and EPA setbacks, fetal nicotine, ASH Thailand and UK, tennis shame, Australian documents, Corporate Activity Project, and 2100 quotes. Tobacco Control 7(3): 320-322

FDA and FSIS issue Listeria health advisory. Fda Consumer 36(6): 5-5

FDA and NIOSH public health advisory: explosions and fires in aluminum oxygen regulators. International Journal of Trauma Nursing 5(2): 39-40

FDA and drug approval. Journal of Vascular and Interventional Radiology 6(6 Pt 2 Suppl): 24s-24s

FDA and mutual recognition agreements: five models of harmonization. Food and Drug Law Journal 53(1): 133-137

FDA and the 1997 Tobacco Settlement: no rules for twelve years?. Food and Drug Law Journal 52(3): 253-258

FDA and the practice of pharmacy: prescription drug regulation before the Durham-Humphrey Amendment of 1951. Pharmacy in History 36(2): 55-70

FDA and the quality and integrity of research. Fda Consumer 36(1): 4-5

FDA and the small manufacturer. Mps. Medical Products Salesman 11(10): 22-23

FDA and tobacco regulation in the 21st century: where are we headed?. Journal of the American Medical Women's Association 55(5): 320-321

FDA announces MedWatch: a new reporting program for health professionals. Aana Journal 61(4): 373-378

FDA announces plan to halt marketing of terfenadine. American Journal of Health-System Pharmacy 54(4): 342-342

FDA announces recall of liquid antibiotics. Pennsylvania Medicine 97(5): 31-31

FDA announces tighter regulation of oral levothyroxine products. American Journal of Health-System Pharmacy 54(19): 2151-2151

FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration. Aids Treatment News: 4-5

FDA application withdrawn to market Viramune for new use. Aids Policy & Law 17(7): 6-6

FDA approval for a combined hepatitis A and B vaccine. Mmwr. Morbidity and Mortality Weekly Report 50(37): 806-807

FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine. Mmwr. Morbidity and Mortality Weekly Report 46(5): 107-109

FDA approval for polyester catheter cuff. Biosensors & Bioelectronics 8(6): Viii-Viix

FDA approval is not the end: getting the most out of taxol. Journal of the National Cancer Institute 85(3): 181-182

FDA approval of a Haemophilus b Conjugate Vaccine combined by reconstitution with an acellular pertussis vaccine. Mmwr. Morbidity and Mortality Weekly Report 45(45): 993-995

FDA approval of a fourth acellular pertussis vaccine for use among infants and young children. Mmwr. Morbidity and Mortality Weekly Report 47(43): 934-936

FDA approval of a second acellular pertussis vaccine for use among infants and young children. Mmwr. Morbidity and Mortality Weekly Report 46(5): 110-111

FDA approval of clinical studies on left ventricular assist system for its therapeutic application. Artificial Organs 20(4): 283-283

FDA approval of comparative claims for prescription drugs--the Moxam case. Drug Information Journal 17(3): 171-175

FDA approval of coronary-artery brachytherapy. New England Journal of Medicine 344(4): 297-299

FDA approval of imiquimod cream in treatment of STD warts. Aids Patient Care and Stds 11(5): 377-378

FDA approval of nevirapine for HIV. American Family Physician 54(5): 1805-1806

FDA approval of the first HIV anti-retroviral from DuPont-Pharma: SUSTIVA (efavirenz). SUSTIVA should be associated with other anti-retrovirals and could be considered a new alternative first line treatment. Allergie et Immunologie 30(8): 268-270

FDA approval provides new option against breast cancer. Pharmaceutical Science & Technology Today 2(12): 471-471

FDA approval sought for frameless, flexible IUD. Contraceptive Technology Update 20(4): 41-42

FDA approvals 'paralyzed'--Dingell. Modern Healthcare 22(37): 68-68

FDA approvals include two new AIDS drugs, pediatric labeling for two protease inhibitors. American Journal of Health-System Pharmacy 54(11): 1233-1233

FDA approvals: '92 in review. Rn 56(3): 50-4, 56-7

FDA approve bark-derived drug. Lancet 347(9015): 1613-1613

FDA approved new drug bulletin. Rn 56(12): 47-50

FDA approved new drug bulletin. Gabapentin (neurontin). Rn 57(7): 39-40

FDA approved new drug bulletin: piperacillin/tazobactam (zosyn), salmeterol xinafoate (serevent). Rn 57(8): 49-52

FDA approved new drug bulletin: rocuronium bromide, venlafaxine hydrochloride. Rn 57(10): 47-8, 51-2

FDA approved new drug bulletin: torsemide (Demadex), trimetrexate glucuronate (neuTrexin). Rn 57(5): 53-56

FDA approved. New drug bulletin: Cisapride and Dornase alfa. Rn 57(4): 39-42

FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Step Perspective 8(1): 7-8

FDA approves 3TC and saquinavir. Food and Drug Administration. Beta 5, 9-5, 9

FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration. Journal of the International Association of Physicians in Aids Care 1(11): 43-43

FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration. Journal of the International Association of Physicians in Aids Care 2(5): 50-51

FDA approves Gleevec for leukemia treatment. Fda Consumer 35(4): 6-6

FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services. Aids Alert 11(1): 11-12

FDA approves Novartis' Gleevec. Expert Review of Anticancer Therapy 1(1): 3-3

FDA approves NuvaRing contraceptive implant. Journal of Gender-Specific Medicine 5(2): 6-6

FDA approves Procleix HIV-1/HCV assay. American Family Physician 65(8): 1693-1694

FDA approves Sustiva (efavirenz) capsules, first once-daily anti-HIV drug. Food and Drug Administration. Research Initiative, Treatment Action 4(6): 13-14

FDA approves Trizivir for HIV infection. Aids Reader 10(12): 701-701

FDA approves Viread for HIV-1 infection. Fda Consumer 36(1): 5-5

FDA approves ViroSeq HIV-1 genotyping system. Expert Review of Molecular Diagnostics 3(1): 6-6

FDA approves ZOMETA for treatment of cancer-related bone complications. Expert Review of Anticancer Therapy 2(2): 137-138

FDA approves abacavir. Food and Drug Administration. Beta 12(1): 3-3

FDA approves alpha-fetoprotein kit amid physician, consumer concerns. Medical World News 24(14): 59-59

FDA approves an AIDS drug from Vertex. Food and Drug Administration. Newsline: 32-32

FDA approves anthrax vaccine license supplements. Fda Consumer 36(3): 5-5

FDA approves antibody-directed cytotoxic agent for acute myeloid leukemia. American Journal of Health-System Pharmacy 57(13): 1202, 1204-1202, 1204

FDA approves baboon bone marrow transplant for AIDS patient. Food and Drug Administration. Beta 7-8

FDA approves cidofovir for treatment of CMV retinitis. Food and Drug Administration. Journal of the International Association of Physicians in Aids Care 2(8): 30-30

FDA approves d4T as alternative to AZT, ddI, or ddC. Food and Drug Administration. Aids Clinical Care 7(1): 4, 10-4, 10

FDA approves device for female sexual dysfunction. Bmj 320(7247): 1427-1427

FDA approves digoxin-toxicity remedy. American Journal of Health-System Pharmacy 58(21): 2021-2021

FDA approves drugs even when experts on its advisory panels raise safety questions. Bmj 318(7188): 944-944

FDA approves efavirenz. Food and Drug Administration. Beta 3-3

FDA approves extra safe chemotherapy drug. Expert Review of Anticancer Therapy 2(6): 618-619

FDA approves first biologic treatment for sepsis. Fda Consumer 36(1): 3-3

FDA approves first drug in new class of antibiotics. Lancet 355(9214): 1523-1523

FDA approves first new class of HIV drugs. Food and Drug Administration. Aids Alert 11(8): 89-89

FDA approves first nucleic acid test for HIV and HCV. Infection Control and Hospital Epidemiology 22(12): 788-789

FDA approves first oral HIV antibody test. Food and Drug Administration. Aids Alert 11(8): 94-94

FDA approves first viral-load test. Food and Drug Administration. Aids Alert 11(8): 94-94

FDA approves first wearable defibrillator. Fda Consumer 36(2): 3-3

FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration. Beta 5-5

FDA approves fusion protein for treatment of lymphoma. Journal of the American Pharmaceutical Association 39(4): 571-572

FDA approves galantamine for Alzheimer's disease. American Journal of Health-System Pharmacy 58(8): 649-649

FDA approves genetic test for women with breast cancer. Bmj 316(7126): 168-168

FDA approves heart laser treatment. Bmj 316(7142): 1409-1409

FDA approves human growth hormone for wasting syndrome. Aids Patient Care and Stds 10(6): 379-380

FDA approves impotence pill. Mayo Clinic Health Letter 16(6): 4-4

FDA approves irinotecan as first-line therapy for colorectal cancer. Oncology 14(5): 652, 654-652, 654

FDA approves latex sensitivity test. Aids Patient Care 9(6): 310-310

FDA approves meat irradiation for pathogen control. Public Health Reports 113(2): 105-105

FDA approves nateglinide for treatment of type 2 diabetes. American Journal of Health-System Pharmacy 58(4): 285, 288-285, 288

FDA approves natural progesterone. Harvard Women's Health Watch 5(11): 7-7

FDA approves nelfinavir. Food and Drug Administration. Gmhc Treatment Issues 11(3): 8-8

FDA approves new Glucose Monitoring System. Diabetes Technology & Therapeutics 1(3): 349-349

FDA approves new PCP drug. Food and Drug Administration. Aids Alert 10(8): 108-108

FDA approves new cholinesterase inhibitor for Alzheimer's disease. American Journal of Health-System Pharmacy 57(11): 1026, 1028-1026, 1028

FDA approves new combination treatment for hepatitis C. Food and Drug Administration. Beta 10-10

FDA approves new dosing for amprenavir and ritonavir combination. Aids Treatment News: 6-7

FDA approves new drug for gastrointestinal stromal tumors. Clinical Journal of Oncology Nursing 6(3): 124-124

FDA approves new drug to reduce risk of stroke. Circulation 101(3): E41-E41

FDA approves new glucose test for adult diabetics. Diabetes Technology & Therapeutics 3(2): 281-281

FDA approves new immunosuppressants. Pharmaceutical Science & Technology Today 2(12): 472-472

FDA approves new inhaler without CFCs. Fda Consumer 35(4): 3-3

FDA approves new kind of lymphoma treatment. Food and Drug Administration. Aids Treatment News: 2-3

FDA approves new protease inhibitor for HIV infection. American Journal of Health-System Pharmacy 57(21): 1942-1942

FDA approves new rapid HIV test. Aids Policy & Law 17(21): 1, 4-1, 4

FDA approves new sterilants. Infection Control and Hospital Epidemiology 19(3): 217-217

FDA approves new versions of two HIV/AIDS drugs. HIV Clinician 12(2): 11-11

FDA approves once-daily efavirenz formulation, revised labeling. Aids Treatment News: 7-7

FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration. Beta 8-8

FDA approves oral therapy for erectile dysfunction. American Journal of Health-System Pharmacy 55(10): 981, 984-981, 984

FDA approves pioglitazone for diabetes. American Journal of Health-System Pharmacy 56(17): 1698-1698

FDA approves quinupristin-dalfopristin for some vancomycin-resistant infections. American Journal of Health-System Pharmacy 56(21): 2174-2174

FDA approves release of Medtronic's revolutionary Stormer Balloon Catheter. Journal of Cardiovascular Management 13(5): 30-30

FDA approves restricted marketing of Lotronex. Fda Consumer 36(4): 4-4

FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food and Drug Administration. Journal of the International Association of Physicians in Aids Care 4(8): 19-25

FDA approves shock wave device for treatment of chronic heel pain. Current Pain and Headache Reports 5(1): 2-2

FDA approves single-injection, bolus-dose thrombolytic agent. American Journal of Health-System Pharmacy 57(14): 1297-1297

FDA approves synthetic blood thinner. Fda Consumer 36(2): 4-4

FDA approves system for digital mammography. Journal of the National Cancer Institute 92(6): 442-442

FDA approves tenofovir. Aids Patient Care and Stds 16(1): 52-52

FDA approves trimetrexate as second-line therapy for Pneumocystis carinii pneumonia. American Journal of Hospital Pharmacy 51(5): 591-592

FDA approves two new approaches to HIV testing. Food and Drug Administration. Positively Aware 7(4): 8-8

FDA approves ultra-sensitive test. Food and Drug Administration. Positively Aware 10(3): 22-22

FDA approves urine test. American Journal of Nursing 96(9): 12-12

FDA approves urine-based Western blot test for HIV. Food and Drug Administration. Aids Policy & Law 13(12): 10-10

FDA approves vaginal sponge as a contraceptive device. Contraceptive Technology Update 4(5): 51-53

FDA approves watch-like device to monitor blood sugar levels. Fda Consumer 35(3): 7-7

FDA approves zafirlukast, first of new type of asthma drug. American Journal of Health-System Pharmacy 53(23): 2778-2778

FDA asks LyphoMed to recall intravenous solution. Modern Healthcare 18(31): 5-5

FDA assigns drug master file to European cancer group. Journal of the National Cancer Institute 90(18): 1331-1331

FDA at war: securing the food that secured victory. Food and Drug Law Journal 53(3): 453-511

FDA audit of investigators and sponsors. Drug Information Journal 16(1-2): 97-101

FDA audit of nonclinical studies. Quality Assurance 4(3): 227-238

FDA backs away from elements of plan to regulate ephedrine supplements. American Journal of Health-System Pharmacy 57(10): 922-922

FDA backs cancer drug for treating MS. Case Manager 11(2): 22-22

FDA ban on home kits debated. Medical World News 30(9): 46-46

FDA bans blood donation by people who have lived in UK. Bmj 319(7209): 535-535

FDA begins to act against black box excimer lasers. Journal of Refractive Surgery 13(4): 336-338

FDA begins to act against unapproved excimer lasers: what took so long?. Journal of Refractive Surgery 12(7): 753-754

FDA board investigates Depo-Provera safety. Contraceptive Technology Update 4(3): 25-27

FDA calls bovine-based vaccines currently safe. JAMA 284(10): 1231-1232

FDA cancels plans requiring patient package inserts for drugs. Ob. Gyn. News 17(5): 5-5

FDA censoring of manufacturers' postmarketing commitments in HIV/AIDS drug approval letters. American Journal of Therapeutics 7(4): 257-263

FDA censures NEJM editor. Bmj 320(7249): 1562-1562

FDA changes labeling for opiate addiction drug. Aids Reader 11(6): 298-298

FDA chief recommends 'tailored', patient-relevant drug information. U. S. Medicine 18(21): 3, 20-3, 20

FDA chief resigns, takes new HHS post. Modern Healthcare 19(46): 6-6

FDA chief says demand by patients for more drug information is genuine. Health Education Reports 2(15): 4-5

FDA cites new data in decision to bar generic conjugated estrogens. American Journal of Health-System Pharmacy 54(12): 1376-1381

FDA clarifies policy on salmonellae in feed, holds workshop on anti-Salmonella additives. Journal of the American Veterinary Medical Association 205(8): 1088-1088

FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration. Aids Treatment News: 5-6

FDA clearance for ritonavir in children with AIDS. Aids Patient Care and Stds 11(3): 194-194

FDA clears 25 new drugs for marketing in 1993. American Journal of Hospital Pharmacy 51(7): 865, 869-865, 869

FDA clears 26 new drugs for marketing in 1992. Clinical Pharmacy 12(4): 247, 253-247, 253

FDA clears Siemens' Opdima digital mammography biopsy & spot imaging system for U.S. marketing. Comprehensive Therapy 23(9): 621-621

FDA clears camera pill to photograph small intestine. Fda Consumer 35(5): 5-5

FDA clears drug trials to combat systemic CMV. Aids Patient Care and Stds 11(4): 295-296

FDA clears new test for rapid identification of breast cancer risk factors. Expert Review of Molecular Diagnostics 2(1): 6-6

FDA clears new treatment for invasive aspergillosis. Oncology Nursing Forum 24(1): 107-107

FDA clears pocket-sized electrocardiograph. Fda Consumer 36(3): 5-5

FDA clears retinal implant for CMV. Aids Patient Care and Stds 10(3): 191-191

FDA clears the way for ending shortage of TB treatment drug. Public Health Reports 108(4): 527-527

FDA clears tuberculosis drug for marketing. Indian Journal of Medical Sciences 53(3): 135-136

FDA clears two glucose test meters. Fda Consumer 36(5): 8-8

FDA comments on activities in states concerning narrow-therapeutic-index drugs. American Journal of Health-System Pharmacy 55(7): 686-687

FDA commissioner notes actions against Internet sites selling prescription drugs. American Journal of Health-System Pharmacy 57(9): 838-838

FDA committee gives new antibiotic mixed endorsement. Clinical Infectious Diseases 32(12): I-i

FDA committee recommends approval for viagra rival. Bmj 320(7242): 1094-1094

FDA committee recommends approval of three new drugs. Food and Drug Administration. Pi Perspective: 10-10

FDA committee recommends stronger warnings against inappropriate use of immediate-release nifedipine. American Journal of Health-System Pharmacy 53(6): 599-600

FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration. Aids Treatment News: 3-3

FDA considering new rules that may clamp down on early showings of works in progress. Modern Healthcare 22(32): 34-34

FDA considering restricted access to "abortion pill". Cmaj 163(5): 586-586

FDA considers DES safe as 'morning-after' pill. JAMA 224(12): 1581-1582

FDA considers OTC drug labeling reform. American Pharmacy Ns35(11): 5-6

FDA considers effects of managed care marketplace on drug promotional practices. Formulary 30(12): 840-841

FDA considers home AIDS tests. Minnesota Medicine 77(8): 55-55

FDA considers home test kits for HIV. American Pharmacy Ns34(9): 11-12

FDA consolidates review process for new pharmaceuticals. Fda Consumer 36(6): 2-2

FDA continuing probe into dialysis deaths. Modern Healthcare 24(5): 14-14

FDA could OK costly blood standards. An expert says that like chicken soup, removal of white cells from blood supply can't hurt. Modern Healthcare 29(48): 8-8

FDA crisis management and the media. Pda Journal of Pharmaceutical Science and Technology 50(3): 144-146

FDA culls nominations for compounding list. American Journal of Health-System Pharmacy 56(14): 1388, 1391-1388, 1391

FDA declines to lift ban on homosexual men as blood donors. Bmj 321(7263): 722-722

FDA delays, unaccountability, raise health care costs and imperil American consumers' lives. Healthspan 12(3): 8-12

FDA device approval regulations. Human Pathology 25(5): 548-549

FDA device regulations and the home care dealer. Medical Products Sales 15(9): 10-11

FDA draws patients into alosetron risk management. American Journal of Health-System Pharmacy 57(19): 1736-1736

FDA drug approval summaries: fulvestrant. Oncologist 7(6): 477-480

FDA drug approvals from 1994 to 1995. General Dentistry 44(2): 114, 116, 118-114, 116, 118

FDA drug list: key to generic substitution. Fda Consumer 13(1): 15-17

FDA drug-review, surveillance processes under scrutiny. American Journal of Health-System Pharmacy 56(5): 404, 406, 408-404, 406, 408

FDA efforts shift to 'urgent' issues. U. S. Medicine 14(2): 13, 16-13, 16

FDA establishes performance standard for electrode lead wires and patient cables. Health Devices 27(1): 34-36

FDA establishes tolerances for tetracyclines in milk. Journal of the American Veterinary Medical Association 213(7): 946-946

FDA evaluates accelerated approval process. Food and Drug Administration. Common Factor: 18-18

FDA evaluating oxaliplatin for advanced colorectal cancer treatment. Journal of the National Cancer Institute 94(16): 1191-1193

FDA examining computer diagnosis. Fda Consumer 29(7): 20-24

FDA expanding its antitrust review by asking for detailed information on proposed Columbia-HCA merger. Modern Healthcare 23(47): 4-4

FDA expert named first 'Americas Fellow'. Fda Consumer 36(6): 6-6

FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James. Aids Treatment News: 1-5

FDA exploring safety aspects of cloned animals. American Journal of Veterinary Research 62(10): 1517-1517

FDA fails to reduce accessibility of paracetamol despite 450 deaths a year. Bmj 325(7366): 678-678

FDA final guidance on software validation. Medical Device Technology 13(3): 20-24

FDA finalizes guidance on DTC broadcast ads. American Journal of Health-System Pharmacy 56(18): 1815-1815

FDA finalizing policy statement on industry-supported activities. American Journal of Hospital Pharmacy 50(3): 391-391

FDA financial disclosure plan flops. Bio/Technology 13(9): 939-940

FDA finds emergency postcoital contraception safe and effective. Reproductive Freedom News 5(12): 7-7

FDA finds new ways to speed treatment to patients. Fda Consumer 27(8): 14-18

FDA focuses on drug and device errors. JAMA 276(16): 1287-1287

FDA funding problems imperil safety of biological products in the United States. JAMA 279(12): 899-901

FDA gets advice on Modernization Act compliance. JAMA 280(14): 1214-1215

FDA gets feedback on informed consent waiver. JAMA 275(5): 347-347

FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards. JAMA 275(6): 423-424

FDA gives final approval to Depo amid concerns over safety, cost and coercion. Washington Memo: 2-3

FDA gives ground to supplement makers. American Journal of Health-System Pharmacy 57(4): 308, 311-308, 311

FDA gives salvage therapy testing a push forward. Aids Treatment News: 3-7, 1

FDA grants marketing clearance of Vistide for the treatment of CMV retinitis. Aids Patient Care and Stds 10(6): 383-384

FDA grants orphan-drug status to Aeterna's Neovastat for kidney cancer. Expert Review of Anticancer Therapy 2(6): 618-618

FDA grants priority review for ZOMETA. Expert Review of Anticancer Therapy 1(3): 325-325

FDA guidelines for endoscope reprocessing. Gastrointestinal Endoscopy Clinics of North America 10(2): 259-264

FDA halts gene therapy trials after leukaemia case in France. Bmj 326(7382): 181-181

FDA handling of ADR reports needs improvement. American Journal of Health-System Pharmacy 57(3): 201-202

FDA has plans to place limits on glove powder. Or Manager 14(3): 1, 24-5, 28

FDA hastening withdrawal of fluoroquinolone approvals for poultry. Journal of the American Veterinary Medical Association 217(10): 1447, 1452-1447, 1452

FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration. Aids Treatment News: 3-4

FDA hears opinions on need for regulation of pharmacoeconomic information. American Journal of Health-System Pharmacy 53(6): 604, 607-604, 607

FDA implementation of standards developed by the International Conference on Harmonisation. Food and Drug Law Journal 52(2): 203-223

FDA import alert: a potentially devastating enforcement tool. Medical Device Technology 9(3): 34-38

FDA in hot water again over cost of proposed drug labeling rule. National Journal 11(38): 1568-1570

FDA in the global village. Fda Consumer 26(6): 14-17

FDA initiative will enhance drug good manufacturing practices. Fda Consumer 36(6): 4-4

FDA insists on more women in drug trials. Bmj 315(7112): 833-833

FDA insists that oestrogen products for menopause carry a warning. Bmj 326(7381): 126-126

FDA investigates complaint of pain in spermicidal condom user. Contraceptive Technology Update 5(3): 34-34

FDA investigates injury reported from "homemade" laser. Journal of Refractive Surgery 11(6): 428-428

FDA involvement in PET: help or hindrance? Part II. Journal of Nuclear Medicine 38(2): 9n-11n, 19n

FDA is strong advocate for dentistry, patients. Today's Fda 12(5): 5, 12-5, 12

FDA issues Hismanal warning. Food and Drug Administration. Beta 3-3

FDA issues alert of possible improper cleaning, disinfecting, and/or sterilizing of reusable medical devices. Joint Commission Perspectives. Joint Commission on Accreditation of Healthcare Organizations 17(3): 10-11

FDA issues concerning conflicts of interest. Irb 12(5): 6-9

FDA issues final enforcement priorities for reprocessed medical devices. Hospital Outlook 3(7): 7, 12-7, 12

FDA issues final guidance on requirements governing single-use medical devices. Report on Medical Guidelines & Outcomes Research 11(19): 5-6

FDA issues final medical device reporting regulation. Healthcare Hazardous Materials Management 9(5): 5-6

FDA issues final rule for classification and reclassification of immunochemistry reagents and kits. American Journal of Clinical Pathology 111(4): 443-444

FDA issues new rule on medical device reporting. Or Manager 12(2): 1, 7-1, 8

FDA issues proposals on nutritional-product health claims. American Journal of Hospital Pharmacy 51(4): 448-448

FDA issues public health advisory on phenylpropanolamine in drug products. Fda Consumer 35(1): 9-9

FDA issues public health notice on chemical softener in plastics. Or Manager 18(10): 15, 18-15, 18

FDA issues regulations on accelerated drug-approval process. Clinical Pharmacy 12(4): 253-254

FDA issues regulations on certification requirements for mammography facilities. Hospital Technology Series 13(2): 1-3

FDA issues reuse requirements. Or Manager 16(9): 7-7

FDA issues urgent notice of recalled injectable drugs. Awhonn Lifelines 5(2): 16-16

FDA issues warning about 'new' tamoxifen risk. Journal of the National Cancer Institute 94(15): 1122-1122

FDA lets air out of medical gas company. Fda Consumer 34(5): 39-39

FDA licences imatinib mesylate for CML. Lancet. Oncology 3(1): 6-6

FDA licenses rotavirus vaccine for infants. American Journal of Health-System Pharmacy 55(21): 2226, 2228-2226, 2228

FDA licensure of NEUMEGA to prevent severe chemotherapy-induced thrombocytopenia. Stem Cells 16 Suppl 2: 207-223

FDA lifts ban on women in early drug tests, will require companies to look for gender differences. JAMA 269(16): 2067-2067

FDA lifts restrictions on AFP test for fetal screening. Mlo: Medical Laboratory Observer 15(8): 27-29

FDA limits research of former AHA president for submitting false information. Bmj 325(7377): 1377-1377

FDA looks at full approval for d4T. Food and Drug Administration. Positively Aware 7(1): 7-7

FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA. Food and Drug Law Journal 54(4): 555-565

FDA may get welcome new funds in its budget. JAMA 281(10): 888-888

FDA may set stricter criteria for glans cap, intravaginal pouch. Contraceptive Technology Update 10(6): 81-82

FDA may "pull the plug" on consent waiver. Lancet 350(9084): 1084-1084

FDA medical device regulation and informed consent. Ajnr. American Journal of Neuroradiology 19(10): 1815-1817

FDA meeting on approving immune therapies: background and comment. Aids Treatment News: 3-7

FDA member disagrees with FDA's selection of senator of the year. Today's Fda 13(8): 30-30

FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice. Federal Register 63(42): 10640-1

FDA moves on glove powder, protein. Or Manager 15(9): 8-8

FDA moves to permit oral contraceptive prescriptions without initial pelvic exam. Washington Memo: 2-3

FDA moving on reuse regulation. Or Manager 16(2): 7-7

FDA must keep traditions but embrace change. Today's Fda 13(8): 14-15

FDA never promised an herb garden--but sellers and buyers eager to see one grow. JAMA 280(18): 1554-1556

FDA news. Food and Drug Administration. Research Initiative, Treatment Action 5(1): 20-20

FDA notification. Shortage of test kits for detecting HIV-1 antibodies. Aids Alert 17(7): 92-92

FDA notifications NucliSens HIV-1 QT is approved. Aids Alert 17(2): 27-28

FDA notifications. Agenerase product label changed. Aids Alert 17(10): 131-131

FDA notifications. Changes approved for Sustiva. Aids Alert 17(4): 51-51

FDA notifications. FDA approves first nucleic acid test to screen for HIV and HCV. Aids Alert 17(5): 66-66

FDA notifications. FDA changes information for stavudine label. Aids Alert 17(5): 67-67

FDA notifications. FDA studies private sector patient information. Aids Alert 17(11): 147-147

FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs. Aids Alert 18(1): 10-11

FDA notifications. New treatment approved for chronic hepatitis B. Aids Alert 17(11): 146-147

FDA notifications. Shortage of Cytovene IV. Aids Alert 17(4): 52-52

FDA notifications. The use of lamivudine has been expanded. Aids Alert 17(10): 131-131

FDA offers CLIA test categorization database, CMS plans inspections in waived and PPMP laboratories, and ICD.9 coding is clarified. Mlo: Medical Laboratory Observer 33(11): 34, 37-34, 37

FDA offers guidance on prophylaxis for exposure to radioiodines. American Journal of Health-System Pharmacy 59(4): 324-326

FDA okays limited use of injectable contraceptive. JAMA 226(7): 735-735

FDA opens door for emergency contraception. Avsc News ) 35(2): 7-7

FDA outlines strategy on reuse. Or Manager 15(12): 7-7

FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration. Journal of the International Association of Physicians in Aids Care 3(1): 24-26

FDA panel advises against omeprazole as over the counter drug. Bmj 321(7269): 1099-1099

FDA panel approves Cygnus's noninvasive GlucoWatch. Diabetes Technology & Therapeutics 2(1): 115-116

FDA panel backs Glaxo Wellcome drug for use in treating chronic hepatitis B. Food and Drug Administration. Newsline: 32-32

FDA panel conditionally approves DNA pap test without ACOG support. Journal of the National Medical Association 94(6): 418-418

FDA panel examines link between breast cancer, pill, says more research needed. Washington Memo: 3-4

FDA panel fails to recommend adefovir approval. Food and Drug Administration. Beta 12(4): 4-4

FDA panel finds insufficient data to approve antimicrobial glove. Aids Patient Care and Stds 10(5): 316-316

FDA panel finds mifepristone safe and effective. Reproductive Freedom News 5(13): 7-8

FDA panel recommends OTC status for second-generation antihistamines. Annals of Allergy, Asthma & Immunology 87(1): 3-5

FDA panel recommends female condom approval; efficacy concerns remain. Washington Memo: 1-2

FDA panel recommends two new cancer drugs for approval. Journal of the National Cancer Institute 93(3): 175-176

FDA panel rejects common cold treatment. Lancet. Infectious Diseases 2(5): 264-264

FDA panel rejects drug for cryptosporidial diarrhea. Food and Drug Administration. Beta 7-7

FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration. Journal of the International Association of Physicians in Aids Care 2(5): 50-50

FDA panel vetoes OTC version of cholesterol drug. Diabetes Technology & Therapeutics 2(3): 484-484

FDA panel votes against approval for bivalirudin. Circulation 99(10): 1277-1277

FDA panels probe efficacy of barrier contraceptives. Washington Memo: 3-4

FDA perspective on risk management programs. Journal of the American Pharmaceutical Association 41(6 Suppl 1): S16-S17

FDA perspective on specifications for biotechnology products--from IND to PLA. Developments in Biological Standardization 91: 3-13

FDA petitioned to 'stop homeopathy scam'. JAMA 272(15): 1154, 1156-1154, 1156

FDA plan for statutory compliance. Notice of availability. Federal Register 63(226): 65000-65040

FDA points to decline in drug review times in 1995. American Journal of Health-System Pharmacy 53(5): 473-4, 476

FDA policy and regulation of stereoisomers: paradigm shift and the future of safer, more effective drugs. Food and Drug Law Journal 54(3): 463-487

FDA policy on women in drug trials. New England Journal of Medicine 329(24): 1815-1816

FDA position on product selection for 'narrow therapeutic index' drugs. American Journal of Health-System Pharmacy 54(14): 1630-1632

FDA poster campaign targets teen smoking. JAMA 278(8): 616-616

FDA posts record number of drug approvals in 1996. American Journal of Health-System Pharmacy 54(5): 494, 497-8

FDA predicts medical device trends. Qrc Advisor 15(4): 10-12

FDA prepares response to questions on sponge safety. Contraceptive Technology Update 4(9): 103-104

FDA prohibits extralabel use of two drug classes. Journal of the American Veterinary Medical Association 211(3): 269-269

FDA proposals: past, present & future. Nutrition 16(11-12): 1125-1125

FDA proposes changes in sunscreen regulations. American Pharmacy Ns34(6): 26-31

FDA proposes constraints on ephedrine dietary supplements. American Journal of Health-System Pharmacy 54(14): 1578-1578

FDA proposes easing research consent requirements in life-threatening situations. American Journal of Health-System Pharmacy 52(21): 2379-2379

FDA proposes mechanism for disseminating information about off-label uses. American Journal of Health-System Pharmacy 55(14): 1449-1450

FDA proposes more stringent pediatric-use labeling of prescription drug products. American Journal of Hospital Pharmacy 50(1): 13, 16-13, 16

FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration. Beta 8-9

FDA proposes new rules regarding trans fatty acids. Awhonn Lifelines 4(1): 17-19

FDA proposes plan for phasing out CFC-containing drug products. American Journal of Health-System Pharmacy 54(9): 1021-1022

FDA proposes rules for health claims on dietary supplements. American Journal of Health-System Pharmacy 55(12): 1239-1240

FDA proposes seafood safety controls. Journal of the American Veterinary Medical Association 204(6): 841-842

FDA proposes testing animal feed antibiotics. Western Journal of Medicine 170(5): 305-305

FDA provides important planning information. American Nurse 31(5): 23-23

FDA public health advisory. Anesthesiology 88(2): 27a-28a

FDA public health advisory: low molecular-weight heparin and spinal/epidural anesthesia or spinal puncture. International Journal of Trauma Nursing 4(2): 56-57

FDA public health advisory: potential for injury from medical gas misconnections of cryogenic vessels. International Journal of Trauma Nursing 7(4): 121-122

FDA public health advisory: risk of electromagnetic interference with medical telemetry systems. International Journal of Trauma Nursing 6(4): 113-114

FDA public health notification: reducing radiation risk from computed tomography for pediatric and small adult patients. Pediatric Radiology 32(4): 314-316

FDA publishes checklist of Y2K high-risk devices. Healthcare Benchmarks 6(9): 99-102

FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration. Aids Treatment News: 8-8

FDA publishes list of Y2K high-risk medical equipment. Hospital Case Management 7(8): 144-146

FDA puts forth proposal to mandate patient information. Formulary 30(10): 622-623

FDA questions San Francisco HIV/AIDS drug advertisements. Aids Policy & Law 16(9): 1, 6-1, 6

FDA questions safety of rifapentine use with HIV drugs -news-. American Journal of Nursing 98(8): 25-25

FDA recognition of consensus standards in the premarket notification program. Biomedical Instrumentation & Technology 32(3): 301-304

FDA recommends bringing controversial IBS drug back. Lancet 359(9316): 1491-1492

FDA recommends hepatitis B drug. Aids Patient Care and Stds 16(10): 511-511

FDA recommends taking patients off Felbatol. Rdh 14(9): 36-36

FDA reconsiders dialyzer relabeling plan after meeting with renal community. Nephrology News & Issues 8(1): 8, 28-8, 28

FDA reform floated in DC. Food and Drug Administration. Gmhc Treatment Issues 9(6): 6-7

FDA reform in Congress: AIDS community absent. Food and Drug Administration. Aids Treatment News: 4-5

FDA reform in Congress: FDA's concerns. Food and Drug Administration. Aids Treatment News: 5-7

FDA reform in Congress: interview with Peter Barton Hutt. Food and Drug Administration. Interview by John S. James. Aids Treatment News: 4-5

FDA reform legislation and its effect on clinical trials. Asaio Journal 46(1): 19-20

FDA reform sails through Congress. Food and Drug Administration. Gmhc Treatment Issues 11(10): 11-12

FDA reform signed into law. Food and Drug Administration. Aids Treatment News: 6-7

FDA reform-real or just more politics?. Cancer BioTherapy & Radiopharmaceuticals 11(4): 227-228

FDA reform. Food and Drug Administration. Update: 10-10

FDA reform: activists' proposals. Food and Drug Administration. Aids Treatment News: 6-8

FDA reform: implications for health economic research and pharmacy practice. Journal of the American Pharmaceutical Association 38(2): 118-120

FDA reform: new Senate bill. Food and Drug Administration. Aids Treatment News: 7-8

FDA reform: new law to impact EP and pacing services at home and abroad. Pacing and Clinical Electrophysiology 21(3): 610-612

FDA reform: the need for a sound science-based approach. Food and Drug Law Journal 51(3): 407-412

FDA reforms drug approval system. U. S. Medicine 19(2): 41-42

FDA refuses companies' request to drop ulcer warning. Bmj 322(7283): 385-385

FDA regulates tobacco marketing to minors. American Journal of Health-System Pharmacy 53(19): 2254-2255

FDA regulation of Internet pharmaceutical communications: strategies for improvement. Food and Drug Law Journal 55(2): 269-292

FDA regulation of analyte-specific reagents (ASRs). Implications for nucleic acid-based molecular testing. Diagnostic Molecular Pathology 5(3): 151-153

FDA regulation of assisted reproductive technology in the USA. Reproductive Biomedicine Online 5(1): 90-91

FDA regulation of black box lasers: approximately 50% of users opt to submit investigational device exemptions. Journal of Refractive Surgery 13(2): 124-125

FDA regulation of clinical software: what does this mean for the industry?. Healthcare Informatics 12(11): 10, 12, 14-10, 12, 14

FDA regulation of genetic testing: institutional reluctance and public guardianship. Food and Drug Law Journal 53(3): 555-591

FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update. Food and Drug Law Journal 51(2): 313-318

FDA regulation of liquid chemical germicides and medical device cleaners. Executive Housekeeping Today 16(3): 21-2; Quiz 23

FDA regulation of medical devices. FDA perspective. Annals of Thoracic Surgery 61(1): 482-4; Discussion 493-8

FDA regulation of medical software. Journal of Health Law 33(1): 129-140

FDA regulation of telemedicine devices. Food and Drug Law Journal 52(4): 517-523

FDA regulation of the safety of MR devices: past, present, and future. Magnetic Resonance Imaging Clinics of North America 6(4): 791-795

FDA regulation on reprocessing single-use devices. The final word is in. Health Devices 29(10): 371-373

FDA regulation: an answer to the questions of human cloning and germline gene therapy. American Journal of Law & Medicine 27(1): 101-124

FDA regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents (executive summary). Tobacco Control 5(3): 236-246

FDA regulatory delays: the crisis ahead. Healthspan 3(3): 10-14

FDA regulatory review and approval processes: a Delphi inquiry. Food and Drug Law Journal 51(1): 143-153

FDA reiterates personal-use importation policy to buyers' clubs. Clinical Pharmacy 12(9): 636-637

FDA rejects extra-label drug use proposal. Journal of the American Veterinary Medical Association 183(9): 929-929

FDA releases Y2K list of critical medical devices. Hospital Peer Review 24(9): 138, 143-138, 143

FDA report identifies DEHP exposure risks. American Journal of Health-System Pharmacy 59(18): 1706-1707

FDA reporting program is key to safety information. American Journal of Health-System Pharmacy 59(23): 2279, 2284, 2289-2279, 2284, 2289

FDA requires blood donor labels. Purchasing Administration 2(7): 19-19

FDA requires manufacturers to fortify grain products with folic acid. Tennessee Medicine 90(2): 60, 64-60, 64

FDA research. Nature Medicine 3(8): 816-816

FDA resolves controversy on nonwoven disposables. Purchasing Administration 3(4): 8-8

FDA rethinks OTC status of bronchodilators, theophylline labeling. American Journal of Health-System Pharmacy 52(20): 2180-2180

FDA reveals plans for antimicrobial susceptibility monitoring. Journal of the American Veterinary Medical Association 208(4): 459-460

FDA review of viral load test kits. Food and Drug Administration. Beta 13-13

FDA review panel gives thumbs up to Norplant. Washington Memo: 3-5

FDA review practices and priorities for drugs used in cancer treatment. Annals of the New York Academy of Sciences 949: 341-344

FDA reviews troglitazone. Diabetes, Obesity & Metabolism 1(2): 65-66

FDA revises informed consent regulations for emergency research. Irb 17(5-6): 19-22

FDA rulemaking after the 104th Congress: major rules enter the twilight zone of review. Food and Drug Law Journal 51(4): 677-695

FDA rules force hospitals to stop reusing, raise costs. Hospital Material Dollar Sign Management 25(12): 1, 9-1,10

FDA safety alert: hazards of precipitation associated with parenteral nutrition. Nutrition in Clinical Practice 11(2): 59-65

FDA says 'Look at the facts' when judging its record on drug approvals. Formulary 30(7): 412, 411-412, 411

FDA says statin cannot be sold over the counter. Bmj 321(7255): 196-196

FDA scrutiny and pediatric clinical investigations. Cost & Quality 33-36

FDA seeks comments on compounding guide. American Journal of Health-System Pharmacy 59(14): 1318-1318

FDA seeks help in evaluating consequences of therapeutic interchange. American Journal of Health-System Pharmacy 54(10): 1149-1149

FDA seeks new-drug applications for 'morning-after' contraception. American Journal of Health-System Pharmacy 54(8): 874, 877-874, 877

FDA seeks public comment on informed consent rules in combat situations. Hastings Center Report 27(5): 43-43

FDA seeks temporary blood donor changes. Food and Drug Administration. Aids Alert 12(2): 15-16

FDA seeks tighter controls over research with human subjects. Hospital Medical Staff 7(12): 1-7

FDA seeks tighter rules on blood donors. Clinical Infectious Diseases 33(8): I-i

FDA sends note to 36 million urging them to know more about medications. American College of Physicians Observer 3(6): 24-25

FDA sets geriatric drug use labeling deadlines. JAMA 278(16): 1302-1302

FDA sets higher standards for mammography. Fda Consumer 33(1): 13-17

FDA sets policy on industry-sponsored educational programs. American Journal of Health-System Pharmacy 55(5): 426-426

FDA sets safety framework for cell and tissue therapies: rules would cover attempted human cloning. Washington Post: A3-A3

FDA sets standards policy, priorities. Mps. Medical Products Salesman 11(4): 14-15

FDA shortened drug approval time in 1995. Public Health Reports 111(4): 290-290

FDA shortens approval periods for new cancer treatments. Alternative Therapies in Health and Medicine 2(4): 28-28

FDA software policy and regulation of medical device software. Food and Drug Law Journal 52(4): 511-516

FDA spells out new reporting requirements. Contemporary Longterm Care 19(3): 60-61

FDA state of affairs. Quality Assurance 2(1-2): 156-161

FDA states policy on pharmacy compounding. Agency follows up on supreme court ruling. American Journal of Health-System Pharmacy 59(13): 1222, 1224-1222, 1224

FDA steps up reg activity on reuse. Or Manager 16(4): 7-8

FDA steps up seafood sampling. Fda Consumer 36(5): 4-4

FDA study finds test kits effective in spotting birth defects. Public Health Reports 113(5): 382-382

FDA supports local programs, seeks help on rules. Journal of Environmental Health 39(1): 17-19

FDA takes action against firms in scandal over generic products. Medical World News 30(17): 14-15

FDA takes action on two major tissue banks. Or Manager 18(10): 9, 15-9, 15

FDA takes action to enforce the law. Fda Consumer 34(3): 7-8

FDA takes dim view of glow-in-the-dark makeup. Fda Consumer 32(1): 38-38

FDA takes on maker of "homemade" excimer lasers. Journal of Refractive Surgery 11(5): 331-332

FDA taking disposable reuse out of the closet. Hospital Material Dollar Sign Management 25(3): 1, 9-1,10

FDA talk papers. Pedicle screws. Journal of Spinal Disorders 7(4): 365-367

FDA taps anti-emetic for treatment of AIDS complication. Rn 56(4): 93-93

FDA targets snack foods industry over allergens. Western Journal of Medicine 174(6): 380-380

FDA tightens rules on advertising. Bmj 315(7106): 447-447

FDA timetable set for reducing use of tobacco by children and adolescents. JAMA 277(10): 778-778

FDA to announce reuse strategy. Or Manager 15(11): 6-6

FDA to develop rules for mandatory bar-code labels. American Journal of Health-System Pharmacy 59(2): 107, 112-107, 112

FDA to fast-track VaxGen experimental AIDS vaccine. Aids Policy & Law 18(1): 9-9

FDA to have greater food regulation powers. Bmj 315(7109): 625-625

FDA to regulate hospital device reuse. Modern Healthcare 29(45): 8-8

FDA to require pediatric studies for drugs commonly used in children. American Journal of Health-System Pharmacy 56(3): 203-203

FDA to the rescue. Fda Consumer 26(8): 14-19

FDA treads delicate line between safety and speed. Oncology 13(1): 16-16

FDA treatment use regulations: a compassionate response. Aids & Public Policy Journal 2(2): 22-32

FDA triple header. Food and Drug Administration. Gmhc Treatment Issues 9(11): 1-3

FDA trying to make case for tobacco regulation. JAMA 271(21): 1648-1648

FDA unveils clues into AIDS therapy. U. S. Medicine 20(2): 21-21

FDA update: 1996. Cancer BioTherapy & Radiopharmaceuticals 11(1): 1-2

FDA use of international standards in the premarket review process. Biomedical Instrumentation & Technology 32(5): 518-526

FDA use of the black box warning: time for reevaluation as a safety tool. Journal of Clinical Anesthesia 14(8): 561-563

FDA user fee plan gets some support from drug makers. Modern Healthcare 22(33): 20-20

FDA user fees approved. Clinical Pharmacy 12(1): 3-3

FDA wants more disclosure of gene-therapy and xenotransplantation risks. Lancet 357(9252): 292-292

FDA wants more restrictions on donated blood. JAMA 286(4): 408-408

FDA wants to know more about reuse of opened-but-unused items. Or Manager 18(9): 1, 7-1, 7

FDA warning on Chinese diet pills containing fenfluramine. Fda Consumer 36(5): 7-7

FDA warning on HIV tests purchased on the Internet. American Family Physician 60(3): 1026, 1029-1026, 1029

FDA warning on raw oysters. Food and Drug Administration. Aids Treatment News: 6-6

FDA warning to manufacturers of AIDS drugs. Bmj 322(7295): 1143-1143

FDA warns Merck over its promotion of rofecoxib. Bmj 323(7316): 767-767

FDA warns Pfizer on failure to report drug problems. Lancet 347(9014): 1546-1546

FDA warns against aminoglycoside residue in cattle. Journal of the American Veterinary Medical Association 219(4): 423-423

FDA warns frequent yeast infections could be early sign of HIV. Public Health Reports 108(2): 259-259

FDA warns of potential protease-inhibitor link to hyperglycaemia. Lancet 349(9068): 1819-1819

FDA warns of stroke risk associated with phenylpropanolamine; cold remedies and drugs removed from store shelves. Circulation 102(21): E9041-3

FDA warns sellers of nicotine lollipops, lip balm. Fda Consumer 36(4): 5-6

FDA weighs approval of HIV RNA test. Lancet 347(9006): 959-959

FDA weighs communicating drug-related risk to patients. JAMA 282(6): 515-515

FDA weighs policing electronic patient record. Hospital Case Management 5(5): 81-83

FDA wishy-washy on fish oil. Health News 6(12): 7-7

FDA withdraws approval of two poultry drugs. Fda Consumer 35(4): 5-5

FDA withholds approval of anti-infection drug; manufacturer's stock price plunges. Modern Healthcare 22(16): 6-6

FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration. Aids Treatment News: 5-6

FDA writes warning letter to users of homemade and illegally imported lasers. Journal of Refractive Surgery 12(5): 569-571

FDA "approval" of medical devices. Health Devices 28(5-6): 235-235

FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?. Anesthesiology 97(1): 287-287

FDA "reform"?. Science 279(5348): 157-158

FDA's Dr. Kennedy answers 12 questions. Pharmacy Times 44(8): 44-47

FDA's FDAMA accomplishments--one year after enactment. Annals of PharmacoTherapy 33(1): 134-134

FDA's Kessler stays, NIH's Healy goes. Lancet 341(8846): 681-682

FDA's Quality System Inspection Technique in Ireland. Medical Device Technology 12(1): 40-41

FDA's Rx for better medication information. Fda Consumer 29(9): 5-10

FDA's Rx for keeping educational programs free of industry bias. American Journal of Health-System Pharmacy 55(23): 2472, 2474-2472, 2474

FDA's approval of MRI units warms up insurers and competition in industry. Modern Healthcare 14(9): 134, 136-134, 136

FDA's aseptic processing: proposed regulation. Journal of Parenteral Science and Technology 47(2): 57-59

FDA's conduct, review, and evaluation of inspections of clinical investigators. Drug Information Journal 21(2): 117-125

FDA's consideration of Codex Alimentarius standards in light of international trade agreements. Food and Drug Law Journal 53(2): 327-335

FDA's consumer education and information programs. Drug Information Journal 12(3): 160-162

FDA's dual standards for biological indicators post threat. Hospital Purchasing News 5(10): 1, 13-1, 13

FDA's efforts frazzling many in blood bank field. Cap Today 12(10): 50-1, 54-6, 58

FDA's efforts to improve access to agency records. Food and Drug Law Journal 53(2): 321-326

FDA's focus on consensus standards: the vision, the heartbreak, the hope. Standardization News 27(5): 24-25

FDA's foods program. Food and Drug Law Journal 56(3): 255-266

FDA's forecast of emerging technologies. Medical Products Sales 13(2): 26-7, 80-3, 85-9

FDA's fraud policy and ethical concerns. Quality Assurance 4(1): 8-11

FDA's guidelines on educational programs. American Journal of Health-System Pharmacy 56(17): 1775-1776

FDA's implementation of FDAMA: an interim balance sheet. Food and Drug Law Journal 56(2): 131-135

FDA's international standards policy. Biomedical Instrumentation & Technology 27(4): 334-336

FDA's mammography facility quality assurance program. Administrative Radiology 13(2): 43-44

FDA's new rule on treatment use and sale of investigational new drugs. Irb 9(4): 1-4

FDA's new vending code: a review. Journal of Environmental Health 42(6): 332-334

FDA's performance standard for electrode lead wires and patient cables. Healthcare Hazard Management Monitor 14(1): 4-5

FDA's performance standard for electrode lead wires and patient cables. Second phase is now being implemented. Health Devices 29(4): 140-141

FDA's proposed regulation of the sale and promotion of tobacco products to minors. Public Health Reports 111(3): 280-285

FDA's responsibility and involvement in the Y2K issue. Biomedical Instrumentation & Technology 32(6): 577-579

FDA's revitalization of medical device review and regulation. Biomedical Instrumentation & Technology 28(3): 220-226

FDA's role in administering the Hatch-Waxman Act. Food and Drug Law Journal 54(2): 211-214

FDA's role in making exclusivity determinations. Food and Drug Law Journal 54(2): 195-203

FDA's role in responding to drug shortages. American Journal of Health-System Pharmacy 59(15): 1423-1425

FDA, CDC alert on scope processing. Or Manager 15(10): 8-8

FDA, Janssen bolster cardiac risk warnings for cisapride. American Journal of Health-System Pharmacy 57(5): 414-414

FDA, Roche to implement new dispensing procedures for isotretinoin. American Journal of Health-System Pharmacy 58(24): 2359-2360

FDA, VA collaborate on HIV drug effects. Fda Consumer 36(2): 5-5

FDA, Zeneca Pharmaceuticals warn of increased uterine-cancer risk with tamoxifen treatment. American Journal of Hospital Pharmacy 51(11): 1380-1381

FDA, off-label use, and informed consent: debunking myths and misconceptions. Food and Drug Law Journal 53(1): 71-104

FDA, reform, and the well-characterized biologic. Analytical Chemistry 68(21): 674a-677a

FDA-USP drug product problem reporting program--an update. Hospital Formulary 14(3): 359-60, 365

FDA-VMAC calls for increased regulation of new antimicrobials; animal groups question conclusion. Journal of the American Veterinary Medical Association 214(6): 767, 772-767, 772

FDA: a science-based agency. Fda Consumer 36(5): 40-40

FDA: approval of generic drug reversed by U.S. Court of Appeals. Journal of Law, Medicine & Ethics 30(1): 120-122

FDA: check Y2K problem list of high-risk equipment. Patient-Focused Care and Satisfaction 7(8): 91-93

FDA: friend or foe?. Medical Device Technology 7(9): 24-30

FDA: making a difference in women's health. Journal of the American Medical Women's Association 49(4): 117-121

FDA: manufacturers can use available research to verify safety of reuse. Nephrology News & Issues 8(9): 9, 11-9, 11

FDA: new E-mail list on HIV/AIDS. Aids Treatment News: 7-7

FDA: one nation under God, with limited access for all. Alternative Medicine Review 5(2): 91-92

FDA: polyurethane condom carries 'extremely misleading' label. Food and Drug Administration. Aids Alert 10(1): 1-4

FDA: polyurethane condom carries "extremely misleading" label. Federal agency allows distribution for public health's sake. Contraceptive Technology Update 16(2): 17-20

FDA: quality of life matters!. Annals of Oncology 6(9): 858-858

FDA: reuse of single-use devices. Infection Control and Hospital Epidemiology 22(6): 398-398

FDA: the regulatory process. Respiratory Care 40(9): 952-956

FDA: user comments should be the driving force behind any regulatory approach. Biomedical Instrumentation & Technology 32(3): 223-223

FDAA bans sale on microwave ovens to women: an imaginary scenario. Plastic and Reconstructive Surgery 91(3): 566-567

FDAMA update. Food and Drug Law Journal 54(1): 21-33

FDAMA's written request list: medicines for children. Lancet 357(9253): 398-398

FDDI information management system for centralizing interactive, computerized multimedia clinical experiences in pediatric rheumatology/Immunology. Medinfo. Medinfo 8 Pt 2: 1204-1208

FDG PET characterization of renal masses: preliminary experience. Clinical Radiology 52(7): 510-515

FDG PET diagnosis of septic kidney in a renal transplant patient. Transplant International 12(2): 156-156

FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. Ajr. American Journal of Roentgenology 174(4): 1005-1008

FDG PET for evaluating breast cancer. Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel: 7-13

FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope 112(2): 381-385

FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging 29(6): 804-808

FDG PET for the localization diagnosis in inflammatory disease of unknown origin--two case reports. Nuklearmedizin. Nuclear Medicine 40(4): N35-N38

FDG PET imaging in patients with lymphoma: a clinical perspective. Journal of Nuclear Medicine 42(4): 609-610

FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. European Journal of Nuclear Medicine and Molecular Imaging 30(2): 288-295

FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET. European Journal of Nuclear Medicine 22(11): 1347-1350

FDG PET in head and neck cancer. Ajr. American Journal of Roentgenology 169(6): 1663-1669

FDG PET in the clinical evaluation of sarcoidosis with bone lesions. Annals of Nuclear Medicine 14(4): 311-313

FDG PET in the management of lymphoma: a clinical perspective . European Journal of Nuclear Medicine and Molecular Imaging 29(4): 449-451

FDG PET in thyroid cancer: thyroxine or not?. Journal of Nuclear Medicine 41(12): 1996-1998

FDG PET of pleural effusions in patients with non-small cell lung cancer. Ajr. American Journal of Roentgenology 175(1): 245-249

FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics 18(4): 805-23; Discussion 823-4

FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland. Orvosi Hetilap 143(21 Suppl 3): 1280-1283

FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid. European Radiology 9(5): 975-978

FDG accumulation in aortic walls. Clinical Nuclear Medicine 26(1): 68-69

FDG accumulation in tumor tissue. Journal of Nuclear Medicine 34(3): 419-421

FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy. Journal of Nuclear Medicine 40(3): 381-386

FDG imaging. Nuclear Medicine and Biology 27(7): 689-690

FDG imaging of a pulmonary artery sarcoma. Annals of Thoracic Surgery 70(4): 1414-1415

FDG imaging without PET. Diagnostic Imaging 20(6): 74-77

FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers. European Journal of Nuclear Medicine and Molecular Imaging 30(2): 274-280

FDG positron emission tomographic imaging of a large abdominal aortic aneurysm. Clinical Nuclear Medicine 28(2): 130-131

FDG positron emission tomographic imaging of pseudo-pseudo tumor. Clinical Nuclear Medicine 27(6): 445-446

FDG positron emission tomographic imaging of the effect of an intrauterine device. Clinical Nuclear Medicine 27(2): 128-129

FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation. Clinical Nuclear Medicine 26(11): 975-976

FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma. Clinical Nuclear Medicine 26(7): 599-601

FDG positron emission tomography detection of pelvic nodal metastases in gynecologic cancer. Ajr. American Journal of Roentgenology 178(3): 762-764

FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. Ajr. American Journal of Roentgenology 179(5): 1151-1157

FDG positron emission tomography for evaluating esophageal cancer. Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel: 13-16

FDG positron emission tomography for the detection of ovarian cancer. Tec Bulletin 19(2): 10-13

FDG positron emission tomography in colorectal cancer. Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel: 6-8

FDG positron emission tomography in diffuse Lewy body disease: a case report. Clinical Nuclear Medicine 25(12): 1004-1006

FDG positron emission tomography in head and neck cancer. Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel: 6-9

FDG positron emission tomography in isolated limb perfusion therapy in patients with locally advanced melanoma: preliminary results. Clinical Nuclear Medicine 26(10): 832-836

FDG positron emission tomography in lymphoma. Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel: 9-10

FDG positron emission tomography in melanoma. Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel: 11-13

FDG positron emission tomography in pancreatic cancer. Tecnologica. Map Supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel: 14-16

FDG positron emission tomography in patients with systemic mastocytosis. Ajr. American Journal of Roentgenology 179(5): 1235-1237

FDG positron emission tomography in the diagnosis of peripheral pulmonary focal lesions. Thoracic and Cardiovascular Surgeon 48(2): 97-101

FDG positron emission tomography to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes. Tec Bulletin 19(2): 14-18

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. European Journal of Nuclear Medicine and Molecular Imaging 29(10): 1317-1323

FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging. Clinical Nuclear Medicine 26(3): 241-242

FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. British Journal of Radiology 74(885): 821-824

FDG uptake within regionally stunned myocardium. American Journal of Cardiac Imaging 9(4): 269-274

FDG- and Dopa-PET in postencephalitic parkinsonism. Journal of Neural Transmission 107(11): 1289-1295

FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer. Annals of Nuclear Medicine 16(6): 409-416

FDG-PET analysis and findings in amnesia resulting from hypoxia. Memory 7(5-6): 599-612

FDG-PET and CT in Evaluation of Chemotherapy in Advanced Head and Neck Cancer. Clinical Positron Imaging 3(1): 1-5

FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis. Journal of Neuropsychiatry and Clinical Neurosciences 12(2): 287-288

FDG-PET as a prognostic factor in high-grade astrocytoma. Journal of Neuro-Oncology 49(2): 157-163

FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. Journal of Computer Assisted Tomography 17(5): 681-687

FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy. European Journal of Nuclear Medicine and Molecular Imaging 29(4): 542-546

FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy. European Journal of Nuclear Medicine 28(9): 1336-1340

FDG-PET detection of primary lung cancer in a patient with an isolated cerebral metastasis . Journal of Cardiovascular Surgery 41(3): 503-505

FDG-PET evaluation of indeterminate pancreatic masses. Journal of Computer Assisted Tomography 20(3): 363-369

FDG-PET finding in early-phase Takayasu arteritis. Journal of Computer Assisted Tomography 23(1): 16-18

FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiation Medicine 19(4): 215-218

FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporosis International 13(9): 755-761

FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. European Journal of Nuclear Medicine 28(11): 1707-1723

FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. European Journal of Nuclear Medicine 27(9): 1305-1311

FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Annals of Oncology 12(4): 479-486

FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Annals of Oncology 13(1): 157-160

FDG-PET for diagnosis and follow-up of inflammatory processes: initial results from the orthopedic viewpoint. Zeitschrift für Orthopadie und Ihre Grenzgebiete 138(5): 407-412

FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging 30(1): 63-71

FDG-PET for response assessment: answers in search of questions. Annals of Oncology 13(3): 345-347

FDG-PET for the evaluation of tumor viability after anticancer therapy. Annals of Nuclear Medicine 8(2): 109-113

FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer 36(3): 297-301

FDG-PET imaging for the staging and follow-up of small cell lung cancer. European Journal of Nuclear Medicine 28(4): 483-488

FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. European Journal of Nuclear Medicine and Molecular Imaging 29(9): 1166-1173

FDG-PET imaging in patients with paraneoplastic syndromes and suspected small cell lung cancer. Journal of Thoracic Imaging 16(2): 89-93

FDG-PET imaging in small cell lung cancer: any value?. Lung Cancer 37(1): 7-7

FDG-PET imaging in the management of non-small-cell lung cancer. Annals of Oncology 13(3): 357-360

FDG-PET imaging of lower extremity muscular activity during level walking. Journal of Orthopaedic Science 8(1): 55-61

FDG-PET improves the staging and selection of patients with recurrent colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging 29(7): 915-921

FDG-PET in an amnestic and hypersomnic patient with bilateral paramedian thalamic infarction. Rinsho Shinkeigaku 33(9): 951-956

FDG-PET in differential diagnosis and grading of chondrosarcomas. Journal of Computer Assisted Tomography 23(4): 603-608

FDG-PET in infectious lesions: The detection and assessment of lesion activity. Annals of Nuclear Medicine 10(2): 185-191

FDG-PET in oncology. Methodological principles and clinical applications. Der Radiologe 39(7): 600-609

FDG-PET in oncology: there's more to it than looking at pictures. Journal of Nuclear Medicine 34(1): 6-11

FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 35(2): 179-187

FDG-PET in the staging of malignant melanoma. Nordisk Medicin 113(9): 301-302

FDG-PET in the staging work-up of patients with suspected intracranial metastatic tumors. Annals of Surgery 230(2): 202-206

FDG-PET of autoimmune-related pancreatitis: preliminary results. European Journal of Nuclear Medicine 27(12): 1835-1838

FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. European Journal of Nuclear Medicine 25(11): 1495-1501

FDG-PET scan in the diagnosis of postmeningococcal pericarditis. Clinical Nuclear Medicine 27(1): 59-59

FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. Journal of Surgical Oncology 77(4): 237-242

FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. European Journal of Nuclear Medicine 28(2): 155-164

FDG-PET, 99mtc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties. European Journal of Nuclear Medicine 28(10): 1496-1504

FDG-PET-scan in subarachnoid hemorrhage. Orvosi Hetilap 143(21 Suppl 3): 1308-1310

FDI Infection Control Checklist. Fdi World 6(5): 20-21

FDI Paris 2000 Congress. Abstracts. International Dental Journal Suppl Fdi Paris: 333-360

FDI Policy statement on fluorides and fluoridation for the prevention of dental caries. Fédération Internationale Dentaire. Dental World 2(3): 11-5, 17

FDI World Dental Federation. Policy statement on dental amalgam. Approved by the FDI's General Assembly, 7 October 1994. Fdi World 4(1): 12-12

FDI World Dental Federation. Policy statement on the equivalency of dental diplomas. Fdi World 4(6): 12-12

FDI World Dental Federation. Position statement on fluorides and dental caries. Fdi World 4(5): 7-8, 10

FDI World Dental Federation. Position statement on tobacco. Fdi World 5(6): 9-9

FDI World Dental Federation. World Health Organization. Consensus statement on dental amalgam. Fdi World 4(4): 9-10

FDI in Korea. Journal of the History of Dentistry 46(2): 84-84

FDI numbering. Angle Orthodontist 67(1): 4-4

FDI policy statement on the human immunodeficiency virus (HIV), the acquired immune deficiency syndrome (AIDS), and dentistry. Revised August 1992. Fédération Dentaire Internationale. Dental World 2(2): 11-18

FDI statement. Improving access to oral health care. Fédération Dentaire Internationale. International Dental Journal 48(6): 549-551

FDI--it's been almost 100 years. Journal 60(8): 676-681

FDI--our window on the world of oral health. Journal 67(1): 9-9

FDI/ADA Orlando Congress abstracts. International Dental Journal 46(5): 459-510

FDI/WHO agreed plan for co-operation. Journal of the Dental Association of South Africa 50(9): 420-420

FDI: quo vadis? Fédération Dentaire Internationale. Schweizer Monatsschrift für Zahnmedizin 104(2): 147, 149-147, 149

FDP and ATC method: a mathematical comparison. Human & Experimental Toxicology 15(10): 855-858

FDP-D dimer or FDP-E fraction. Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 569-572

FDP-E fraction. Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 2: 30-33

FDR and hypertension: if we'd only known then what we know now. Geriatrics 51(1): 29-32

FDR: handicapped American. Public Welfare 42(2): 6-18

FDS Study Day care of the medically and dentally compromised child. Thursday 16 March 2000. Annals of the Royal College of Surgeons of England 82(7 Suppl): 227-228

FDTD electromagnetic and thermal analysis of interstitial hyperthermic applicators. Finite-difference time-domain. IEEE Transactions on Bio-Medical Engineering 42(10): 973-980

FDTD simulation of finite-amplitude pressure and temperature fields for biomedical ultrasound. Journal of the Acoustical Society of America 105(5): L7-12

FDTD simulations for ultrasound propagation in a 2-D breast model. Ultrasonic Imaging 18(1): 25-34

FE-simulation of bone modeling around an implant in the mandible in two-stage versus one-stage implantation. Biomedizinische Technik. Biomedical Engineering 47 Suppl 1 Pt 1: 298-301

FEANI (European Federation of National Engineering Associations) and its register of professional engineers. Health Estate Journal 44(6): 17-8, 20

FEBS Letters volumes 442-464 (1999) master index. Febs Letters 464 Suppl: 1-124

FEC chain purchasing moves into big time. Medical Products Sales 15(5): 42-43

FECS 20th Birthday--a survivor speaks. European Journal of Cancer 38(1): 8-10

FECS Clinical Award lecture 1989. Factors in decision making in the treatment of breast cancer. Federation of European Cancer Societies. RadioTherapy and Oncology 55(3): 205-16;discussion 217-8

FECs face backlash from rapid growth. Medical Products Sales 14(12): 1, 6, 9-10

FECs offer high quality care and convenience. Patient Care 16(18): 109-11, 114-5

FECs: a fast track market. National Association of Freestanding Emergency Centers. Medical Products Sales 14(9): 58-62

FEDL could end frustration of treating unexplained vulvar pain. Clinical Laser Monthly 12(8): 123-125

FEHB premiums to leap. National Underwriter. Life & Health Insurance Edition 86(44): 1, 24-1, 24

FELASA guidance paper for the accreditation of laboratory animal diagnostic laboratories. Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Accreditation of Diagnostic Laboratories. Laboratory Animals 33 Suppl 1: S19-S38

FELASA guidelines for education of specialists in laboratory animal science (Category D). Report of the Federation of Laboratory Animal Science Associations Working Group on Education of Specialists (Category D) accepted by the FELASA Board of Management. Laboratory Animals 33(1): 1-15

FELASA recommendations for the accreditation of laboratory animal science education and training. Laboratory Animals 36(4): 373-377

FELASA recommendations for the education and training of persons carrying out animal experiments (Category B). Report of the Federation of European Laboratory Animal Science Associations Working Group on Education of Persons Carrying out Animal Experiments (Category B) accepted by the FELASA Board of Management. Laboratory Animals 34(3): 229-235

FELASA recommendations for the health monitoring of mouse, rat, hamster, guineapig and rabbit breeding colonies. Laboratory Animals 28(3): 279-280

FEM analysis of predicting electrode-myocardium contact from RF cardiac catheter ablation system impedance. IEEE Transactions on Bio-Medical Engineering 49(6): 520-526

FEMA to let L.A. decide how to spend federal relief funds. Modern Healthcare 25(45): 21-21

FEMS Symposium on Lignin Biodegradation and Transformation. Proceedings. Lisbon, Portugal, 18-21 April 1993. Fems Microbiology Reviews 13(2-3): 121-390

FENS 2000 - Federation of European Neuroscience Societies millennium meeting. Trends in Neurosciences 22(10): 427-428

FENS Program for nutrition education in medical schools. Federation of European Nutrition Societies. Annals of Nutrition & Metabolism 43(1): 66-68

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study. British Journal of Cancer 77(7): 1149-1154

FES cycling may promote recovery of leg function after incomplete spinal cord injury. Spinal Cord 38(11): 680-682

FES gait restoration and balance control in spinal cord-injured patients. Progress in Brain Research 97: 387-396

FES interest group mooted. Australian Journal of PhysioTherapy 44(1): 38-38

FES standing: control by handle reactions of leg muscle stimulation (CHRELMS). IEEE Transactions on Rehabilitation Engineering 4(4): 280-284

FESCC survey on accreditation and post-graduate training in clinical chemistry in European countries. Federation of European Societies of Clinical Chemistry. Clinical Chemistry and Laboratory Medicine 38(4): 371-376

FESTIVAL study is not a festival. American Journal of Cardiology 88(11): 1349-1349

FET-microbial sensor for xylose detection based on Gluconobacter oxydans cells. Biosensors & Bioelectronics 11(4): 401-408

FET3P, ceruloplasmin, and the role of copper in iron metabolism. Advances in Protein Chemistry 60: 221-269

FETAL AND NEONATAL EDITION january 2000 issue. Archives of Disease in Childhood 82(1): 66-66

FETAL AND NEONATAL EDITION july 2000 issue. Archives of Disease in Childhood 83(1): 81-81

FETAL AND NEONATAL EDITION july issue. Archives of Disease in Childhood 81(1): 27-27

FETAL AND NEONATAL EDITION march 2000 issue. Archives of Disease in Childhood 82(3): 265-265

FETAL AND NEONATAL EDITION may 2000 issue. Archives of Disease in Childhood 82(5): 393-393

FEV(1) as a guide to lung transplant referral in young patients with cystic fibrosis. Pediatric Pulmonology 30(3): 198-202

FEV1 and PEF in COPD management. Thorax 54(5): 468-469

FF-beta-D-arabinofuranosyluracil. Acta Crystallographica. Section C, Crystal Structure Communications 55: 632-633

FFR for all. Catheterization and Cardiovascular Interventions 54(4): 435-436

FFR valid in patients after myocardial infarction. Journal of Invasive Cardiology 12(9): 487-487

FFT Doppler technology processes blood velocity information rapidly. Modern Healthcare 11(1): 90, 92-90, 92

FFT analysis of blood flow in hepatocellular carcinoma. Nihon Rinsho. Japanese Journal of Clinical Medicine 59 Suppl 6: 258-263

FFT approximation in Alzheimer's disease. Italian Journal of Neurological Sciences 19(4): 211-216

FG7142 causes opposite changes in [3H]GABA release from nigrocollicular regions. Pharmacology, Biochemistry, and Behavior 44(2): 333-338

FGD PET in a patient with pseudofractures from osteomalacia. Revista Espanola de Medicina Nuclear 21(1): 34-35

FGF and EGF are mitogens for immortalized neural progenitors. Journal of Neurobiology 25(7): 797-807

FGF is an essential regulator of the fifth cell division in preimplantation mouse embryos. Developmental Biology 198(1): 105-115

FGF receptor 1 expression in experimental choroidal neovascularization. Japanese Journal of Ophthalmology 40(3): 329-338

FGF signaling is essential for the early events in the development of the chick nervous system and mesoderm. International Journal of Developmental Biology 45(8): 877-885

FGF-1 but not FGF-4 secreted by carcinoma cells promotes in vitro and in vivo angiogenesis and rapid tumor proliferation. Growth Factors 12(1): 37-47

FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias. Leukemia 15(2): 228-237

FGF-2 converts mature oligodendrocytes to a novel phenotype. Journal of Neuroscience Research 50(2): 215-228

FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium 6(3): 185-195

FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells. Glia 11(1): 47-56

FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 28(2): 385-397

FGF-2: specific activity in kidney?. Kidney International 56(3): 1156-1157

FGF-4 gene therapy GENERX--Collateral Therapeutics. Biodrugs 16(1): 75-76

FGF-4 or FGF-2 administration induces apoptosis, collagen type I expression, and mineralization in the developing coronal suture. Journal of Craniofacial Surgery 12(4): 399-400

FGF-8 is associated with anteroposterior patterning and limb regeneration in Xenopus. Developmental Biology 192(2): 455-466

FGF10 can induce Fgf8 expression concomitantly with En1 and R-fng expression in chick limb ectoderm, independent of its dorsoventral specification. Development, Growth & Differentiation 41(6): 665-673

FGF10 maintains stem cell population during mouse incisor development. Connective Tissue Research 43(2-3): 201-204

FGF10, a key factor for limb and lung formation. Seikagaku. Journal of Japanese Biochemical Society 72(4): 288-291

FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Molecular Therapy 2(2): 153-160

FGF2-targeted adenoviral vectors for systemic and local disease. Current Opinion in Molecular Therapeutics 1(5): 573-579

FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12. Bulletin du Cancer 87(12): 887-894

FGFR2 gene mutation (Tyr375Cys) in a new case of Beare-Stevenson syndrome. American Journal of Medical Genetics 76(4): 362-364

FGFR2 mutations among Thai children with Crouzon and Apert syndromes. Journal of Craniofacial Surgery 14(1): 101-4; Discussion 105-7

FGFR2 mutations and acne. Lancet 352(9129): 668-669

FGFR3 dysregulation and clinical outcome in myeloma. British Journal of Haematology 120(1): 166-166

FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma. Blood 92(8): 2987-2989

FGFs as multifunctional signaling molecules: diversity of structure and function. Seikagaku. Journal of Japanese Biochemical Society 73(7): 525-535

FGM in Cameroon. Newsletter: 16-16

FGM: Senegalese women protected by law. Africa Health 21(4): 40-40

FHA mortgage insurance for healthcare providers. Healthcare Financial Management 38(10): 52-58

FHA mortgage insurance program for hospitals threatened in Congress. Modern Healthcare 15(12): 164-166

FHA working to streamline hospital loan guarantee program. Modern Healthcare 22(27): 33-34

FHA worried about looming N.Y. cuts. Modern Healthcare 25(15): 28-28

FHF-2 in the turkey (Meleagris gallopavo). Animal Biotechnology 13(2): 203-209

FHI quinacrine studies. Network 16(1): 27-27

FHI study examines N-9 film effect on STDs. Contraceptive update. Network 17(3): 4-5

FHI to oversee AIDS vaccine trials. Network 14(3): 2-2

FHI's role at the Cairo conference. Introduction. Network 15(2): 18-19

FHI's role in search for nonsurgical sterilization. Network 14(4): 26-29

FHIT as tumor suppressor: mechanisms and therapeutic opportunities. Cancer Biology & Therapy 1(3): 232-236

FHIT gene and cancer. Environmental Health Perspectives 104(8): 818-819